Conditions & Treatments
Yale Cancer Center
Yale Cancer Center is a collaboration involving nationally and internationally renowned physicians and scientists from Yale Medicine, Yale School of Medicine and Smilow Cancer Hospital. This partnership enables us to provide the best approaches for prevention, detection, diagnosis and treatment of cancer.Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 43 years, Yale Cancer Center is one of only 49 of these centers in the nation. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing illness and death from cancer through scientific research, cancer prevention and...
Yale Center for Genomic HealthGenetics
The Yale Center for Genomic Health (YCGH) will operate one of the largest DNA sequencing projects of its kind in the United States. This project will enable both research as well as important health care interactions for some participants. This effort, called the "Generations Project," will launch in 2019 with a goal of enrolling more than 100,000 volunteers.Volunteer participants who enroll in the Generations Project will have their DNA analyzed at a level of detail not possible through at-home genetic testing kits. The goal of this research is to learn more about human health and disease to find better ways to keep people healthy and treatments when they are sick.The volunteers’ genomic data will be linked to electronic health records in...
Yale Multiple Sclerosis Center and MS AccessMultiple Sclerosis & Other Inflammatory Brain Disease
Yale Multiple Sclerosis Center and MS Access Because multiple sclerosis (MS) progresses rapidly, it’s important for patients newly diagnosed with the disease to see a neurologist and begin treatment quickly. MS Access is a program launched by the Yale Multiple Sclerosis Center to provide treatment for multiple sclerosis patients as soon as possible—often within 48 hours. This access to early treatment from our team of expert, fellowship-trained neurologists can be critical in helping to prevent the scarring of brain tissue and permanent brain damage that can occur in patients with MS. In addition, this program gives patients access to promising new therapies or medications that may not be available to the general public.The Yale Multiple...